| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9868 |
| Human Intestinal Absorption | HIA- | 0.7458 |
| Caco-2 Permeability | Caco2- | 0.6915 |
| P-glycoprotein Substrate | Non-substrate | 0.8723 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9435 |
| Non-inhibitor | 0.9596 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9497 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7984 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8692 |
| CYP450 2D6 Substrate | Non-substrate | 0.8528 |
| CYP450 3A4 Substrate | Non-substrate | 0.7126 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8947 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8759 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9335 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8574 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9413 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9653 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8422 |
| Non-inhibitor | 0.9730 |
| AMES Toxicity | Non AMES toxic | 0.8280 |
| Carcinogens | Carcinogens | 0.6317 |
| Fish Toxicity | Low FHMT | 0.6447 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5000 |
| Honey Bee Toxicity | High HBT | 0.8424 |
| Biodegradation | Ready biodegradable | 0.8350 |
| Acute Oral Toxicity | I | 0.4090 |
| Carcinogenicity (Three-class) | Non-required | 0.5011 |